Navigation Links
Cancer survivors at greater risk of birth complications; special monitoring needed
Date:7/1/2009

Amsterdam, The Netherlands: Survivors of childhood cancer run particular risks when pregnant and should be closely monitored, the 25th annual conference of the European Society of Human Reproduction and Embryology heard today (Wednesday 1 July). Dr. Sharon Lie Fong, of the Department of Obstetrics and Gynaecology, Erasmus MC University Medical Centre, Rotterdam, The Netherlands, said that, although such women may have conceived spontaneously and considered themselves to be perfectly healthy, their deliveries should always take place in a hospital.

Dr. Lie Fong and colleagues studied data on the pregnancies of 40 women who had been treated for cancer during their childhood, the majority of them for leukaemia, but also for solid tumours. Six had had radiation treatment directly to the abdomen. The data were compared with those from a control group of more than 9,000 women who had not had cancer treatment. All data were obtained from The Netherlands Perinatal Register, a nationwide database of pregnancy outcomes. Data were matched for age at pregnancy, year and month of delivery, and the number of times the woman had given birth.

"This is the first such study on pregnancy outcome in childhood cancer survivors as compared with normal, healthy women," said Dr. Lie Fong. "Although we found no differences between most of the survivors and the control group, the women treated with abdominal radiotherapy delivered more prematurely. These women also had more postpartum haemorrhages the loss of more than one litre of blood after delivery."

The team did not investigate overall fertility and miscarriage rates, but they believe that it is possible that the fertility of all the cancer survivors may be compromised. "We know that radiotherapy and some chemotherapy treatments are toxic to the ovarian follicles," said Dr. Lie Fong, "and, in an earlier study, we had already found that ovarian reserve is smaller in adult survivors of childhood cancer tha
'/>"/>

Contact: Mary Rice
mary@mrcommunication.org
European Society for Human Reproduction and Embryology
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Calling All Runners: Join the Fight Against Cancer
2. Study identifies biomarker that safely monitors tumor response to new brain cancer treatment
3. Lung Cancer Alliance Releases Updated 2009 Facts About Lung Cancer
4. Metabolic factors may play a role in risk for breast cancer
5. Possible benefit from online genetic testing for lung cancer
6. Metabolic Syndrome May Make Breast Cancer More Likely
7. Save the ta-tas Calling on Women to Join the Love/Avon Army of Women to Unlock the Key to Breast Cancer Prevention
8. Damon Runyon Cancer Research Foundation awards $2.7M to 7 top young clinical investigators
9. Bladder Cancer No Longer a Death Sentence
10. Peregrine Pharmaceuticals Completes Planned Patient Enrollment in Bavituximab Phase I Cancer Trial
11. AACE Response to Insulin Glargine Cancer Risk Articles in Diabetologia
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 2BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 3BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 4Shanghai ChemPartner Is Pleased to be Part of Agios' Groundbreaking Cancer Research 2Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 2Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 3Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 4Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 5Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 6Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 7Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 8Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 9Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 10Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 11Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 12Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 13Immune responses to flu vaccine are diminished in lupus patients 53173 1Immune responses to flu vaccine are diminished in lupus patients 53173 2Nanoparticle delivered suicide genes slowed ovarian tumor growth 9423 1Nanoparticle delivered suicide genes slowed ovarian tumor growth 9423 2Reducing risk of hospitalization in the elderly 9421 1Reducing risk of hospitalization in the elderly 9421 2